Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Child Adolesc Psychiatry ; 19(3): 227-35, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20213231

ABSTRACT

Obsessive-compulsive disorder (OCD) is characterized by recurrent, intrusive and disturbing thoughts as well as by repetitive stereotypic behaviors. Epidemiological data are similar in children and adults, i.e., between 1 and 3% of the general population suffer from OCD. Children with OCD are often seriously impaired in their development. OCD, especially of early onset, has been shown to be familial. Several candidate genes of predominantly neurotransmitter systems have been analyzed and a total of three genome-wide linkage scans have been performed until now. Analyses of candidate genes in linkage regions have not provided evidence for their involvement in OCD, with the exception of the glutamate transporter gene SLC1A1 on 9p24. Genome-wide association analyses are in progress and the results will promote further independent replication studies. The consideration of subtypes regarding age of onset, symptom dimensions and/or comorbid disorders is needed.


Subject(s)
Diseases in Twins/genetics , Genetic Markers/genetics , Genetic Predisposition to Disease/genetics , Obsessive-Compulsive Disorder/genetics , Adolescent , Child , Chromosome Mapping , Diseases in Twins/diagnosis , Genome-Wide Association Study , Humans , Obsessive-Compulsive Disorder/diagnosis , Phenotype
2.
J Neural Transm (Vienna) ; 115(10): 1385-92, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18726139

ABSTRACT

Sustained drug delivery providing continuous dopaminergic stimulation is thought to prevent or delay the induction of motor complications (dyskinesia) in Parkinson's disease, whereas pulsatile administration is supposed to promote them. This study investigated the inducibility of sensitization and abnormal involuntary movements (AIMs), comparing continuous and pulsatile administration of rotigotine with pulsatile administration of 3,4-dihydroxy-L-phenylalanine (L-DOPA) for reference. Rats were unilaterally lesioned with 6 hydroxydopamine (6-OHDA). For pulsatile administration, L-DOPA-methylester (10 mg/kg L-DOPA i.p.) or rotigotine (1 mg/kg i.p.) were administered once or twice daily. For continuous administration, a slow release formulation of rotigotine was injected s.c. at a dose of 1 mg/kg every 48 h (experiment I) or every 24 h (experiment II). Pulsatile administration of rotigotine and L-DOPA caused contraversive rotations increasing progressively upon each successive treatment. AIMs started to occur after the second administration of L-DOPA but hardly after pulsatile rotigotine. Continuous rotigotine increased rotations, which reached a plateau after the second administration. No AIMs were observed under continuous administration. The continuous administration of rotigotine did not induce sensitization or AIMs, suggesting that continuous stimulation of dopaminergic receptors by rotigotine has no propensity to induce dyskinesia in this experimental model.


Subject(s)
Dopamine Agonists/administration & dosage , Dyskinesia, Drug-Induced , Dyskinesias/drug therapy , Parkinsonian Disorders/drug therapy , Tetrahydronaphthalenes/administration & dosage , Thiophenes/administration & dosage , Adrenergic Agents/toxicity , Animals , Male , Oxidopamine/toxicity , Parkinsonian Disorders/complications , Rats , Rats, Sprague-Dawley , Rotation
SELECTION OF CITATIONS
SEARCH DETAIL
...